mountsinaihospital.com
The postdoctoral fellow will investigate the use of selective modified mRNA to treat diseases such as diabetic foot, skin ageing, and cardiac regeneration using murine and pig models. The role involves in vitro screening, mRNA preparation, lipid nanoparticle formulation, high‑throughput data analysis, and designing in vivo studies to advance candidates toward clinical trials.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for mountsinaihospital.com.
8% below the average for this role
Postdoctoral Fellow
oraclecloudinfrastructure
Postdoctoral Fellow
oraclecloudinfrastructure
Senior Associate Scientist Lnp Formulations United States
alnylam
2026 Summer Intern | Formulation & Delivery Sciences
iSi Environmental
Research Scholar
New York University
Senior Scientist, Delivery Technologies
CSL Behring Australia